Rating History for UroGen Pharma (URGN) by Ladenburg Thalmann
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/11/2026 | Kevin DeGeeter | New Coverage | Buy (N/A) |
43.00 (N/A) |
29.40 (35.47) |
20.65% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/11/2026 | Kevin DeGeeter | New Coverage | Buy (N/A) |
43.00 (N/A) |
29.40 (35.47) |
20.65% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||